Young Conaway's Commercial Litigation Chair and Partner, Melanie Sharp, will be moderating a panel at the American Conference Institute's 13th Summit on Biosimilars and Innovator Biologics held in Boston on June 29, 2022.  The session entitled, "Advocating for Diversity in IP:  Practical Ideas for Implementing Change," will focus on strategies members of the pharmaceutical IP community can apply in order to realize the full benefits of a diverse workforce.  Ms. Sharp will be joined by esteemed panelists:

To learn more, visit the Summit's website https://www.americanconference.com/biosimilars/agenda/.